Skip to main content
Signal8

DEBUONO LAUREEN

SEC insider (Form 3/4/5 filer). CIK 0001034447. Director at Rani Therapeutics Holdings, Inc. (RANI). 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 16, 2024. Located in SAN JOSE, CA.

Companies DEBUONO LAUREEN has filed insider reports for

  • Rani Therapeutics Holdings, Inc. (RANI): Director
DEBUONO LAUREEN profile photo

DEBUONO LAUREEN

CIK: 0001034447

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Rani Therapeutics Holdings, Inc. logo
RANI

Rani Therapeutics Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Dec 16, 2024
    Disposition

    Stock Option (Right to Buy)

    Direct
    101.3K shares-
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Dec 16, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    101.3K shares-
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Dec 16, 2024
    Disposition

    Stock Option (Right to Buy)

    Direct
    18.9K shares-
  • Rani Therapeutics Holdings, Inc. logo
    RANI

    Rani Therapeutics Holdings, Inc.

    Dec 16, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    18.9K shares-

1-4 of 4